Evista is the trade name for the drug Raloxifene, a type of drug called a selective estrogen receptor modulator (SERM). Other SERM's include the older drugs Nolvadex (Tamoxifen) and Clomid (Clomiphene). Raloxifene is anti-estrogenic in the breast while it is pro-estrogenic in bone.
OFF LABEL- More recently, men with gynecomastia have been using Evista to help combat this condition while bodybuilders will also use Evista to combat the effects of steroids that convert to estrogen or to restore endogenous testosterone function after a cycle of steroids.
Evista is considered more potent than older drugs which is one reason it has won favour among some medical doctors while its bone enhancing abilities makes it the first choice treatment for osteoporosis.
Evista is primarily used in the treatment of post-menopausal women with osteoporosis where it not only helps increase bone integrity, it also reduces the risk of breast cancer. As noted previously, it is also being used by men for either reducing symptoms of gyno or to restore testosterone levels during PCT.
Evista should be used as directed by a medical practitioner for women prescribed this for osteoporosis. Among those individuals using it for off-label purposes it is normally only used when they are using steroids that convert to estrogen or else, for a period of 2-3 weeks at the end of a steroid cycle. Always refer to the product literature.